INIFY® Prostate Screening

INIFY® Prostate Screening is an AI-powered tool that provides pathologists with valuable decision support when identifying cancer in prostate biopsies. Exploring the advantages of today’s digital technology in whole new ways, and drawing on the very latest breakthroughs in deep learning, INIFY Prostate Screening empowers pathologists faced with today’s ever-increasing workload. It makes room for smarter, more accurate and faster decisions, is proven to be robust across different labs and scanners, and is adaptable to different workflows and user needs. INIFY Prostate Screening builds on the resilient foundation of innovation, technical know-how and professionalism that has been a trademark of ContextVision for the last 30 years.
2020-06-29
We are proud to announce that INIFY Prostate Screening has been granted CE mark status, and is now available for routine clinical use within the European Union.
Read the press release

Power to the pathologist

Smart
An algorithm is only as smart as its underlying training data. The predicting AI-based engine in INIFY Prostate Screening is built on deep learning algorithms that are meticulously trained.
Read more
Accurate
For real diagnostic confidence, accuracy is everything, and this is where we truly shine.
Read more
Robust
INIFY Prostate Screening’s algorithms stand up impressively to known differences between labs, enabling a plug-and-play approach. 
Read more
FAST
INIFY Prostate Screening is designed to help pathologists make the most of their valuable time.
 Read more 
ADAPTABLE
Our experienced specialists have been working closely together with pathologists from all over the world, creating tools that can be attuned to diverse clinical workflows and user needs. 
Read more
RESILIENT
Innovation, technical know-how and professionalism – these are the cornerstones of ContextVision’s enduring market leadership for the last 30 years.
Read more